Related Experiment Video
Updated: Aug 1, 2026
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Disruption of mitochondrial respiration by melatonin in MCF-7 cells
A E Scott1, G N Cosma, A A Frank
1Department of Environmental Health, Colorado State University, Fort Collins, Colorado, USA. Aaron.Scott@uchsc.edu
Abstract:
Clinical and laboratory studies have provided evidence of oncostatic activity by the pineal neurohormone melatonin. However, these studies have not elucidated its mechanism of action. The following series of MCF-7 breast tumor cell studies conducted in the absence of exogenous steroid hormones provide evidence for a novel mechanism of oncostatic activity by this endogenous hormone. We observed a 40--60% loss of MCF-7 cells after 20-h treatment with 100 nM melatonin, which confirmed and extended previous reports of its oncostatic potency. Interestingly, there were no observed changes in tritiated thymidine uptake, suggesting a lack of effect on cell cycle/nascent DNA synthesis. Further evidence of a cytocidal effect came from morphologic observations of acute cell death and autophagocytosis accompanied by degenerative changes in mitochondria. Studies of mitochondrial function via standard polarography revealed a significant increase in oxygen consumption in melatonin-treated MCF-7 cells. Enzyme-substrate studies of electron transport chain (complex IV) activity in detergent permeabilized cells demonstrated a concomitant 53% increase (p < 0.01) in cytochrome c oxidase activity. Additional studies of succinate dehydrogenase activity (complex II) as determined by reduction of (3-4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide demonstrated a significant increase (p < 0.05) in melatonin-treated cells and further confirmed the accelerated ET activity. Finally, there was a 64% decrease (p < 0.05) in cellular ATP levels in melatonin-treated cells. The G-protein-coupled melatonin receptor antagonist luzindole abrogated the cytotoxic and mitochondrial effects. These studies suggest a receptor-modulated pathway of cytotoxicity in melatonin-treated MCF-7 tumor cells with apparent uncoupling of oxidative phosphorylation.
Insights
Melatonin causes breast cancer cell death by increasing mitochondrial activity and decreasing ATP levels, not by affecting DNA synthesis. This novel mechanism involves receptor modulation and uncoupling of oxidative phosphorylation.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Melatonin, a pineal neurohormone, exhibits oncostatic activity.
- The precise mechanism of melatonin's anti-cancer effects remains unclear.
- Previous studies suggest melatonin's role in inhibiting tumor growth.
Purpose of the Study:
- To investigate the mechanism of melatonin's oncostatic activity in MCF-7 breast tumor cells.
- To explore melatonin's effect on cell death, mitochondrial function, and energy metabolism.
- To determine if melatonin's effects are mediated through its receptor.
Main Methods:
- MCF-7 cells were treated with melatonin (100 nM) for 20 hours.
- Cell death was assessed via morphology and loss of cell count.
- Mitochondrial function was evaluated using polarography, enzyme assays (cytochrome c oxidase, succinate dehydrogenase), and ATP level measurements.
- The effect of the melatonin receptor antagonist luzindole was investigated.
Main Results:
- Melatonin treatment led to a 40-60% loss of MCF-7 cells without affecting tritiated thymidine uptake.
- Morphological analysis indicated acute cell death and autophagocytosis with mitochondrial damage.
- Oxygen consumption and activities of cytochrome c oxidase (Complex IV) and succinate dehydrogenase (Complex II) significantly increased.
- Cellular ATP levels decreased by 64%.
- Luzindole blocked the cytotoxic and mitochondrial effects of melatonin.
Conclusions:
- Melatonin induces cytotoxicity in MCF-7 cells through a novel receptor-modulated pathway.
- The mechanism involves increased mitochondrial respiration and electron transport chain activity, leading to uncoupling of oxidative phosphorylation and decreased ATP levels.
- Melatonin's oncostatic effect is independent of direct DNA synthesis inhibition.
